ES2193144T3 - Compuestos de dna que comprenden secuencias que codifican manuronano c-5-epimerasa. - Google Patents

Compuestos de dna que comprenden secuencias que codifican manuronano c-5-epimerasa.

Info

Publication number
ES2193144T3
ES2193144T3 ES93923068T ES93923068T ES2193144T3 ES 2193144 T3 ES2193144 T3 ES 2193144T3 ES 93923068 T ES93923068 T ES 93923068T ES 93923068 T ES93923068 T ES 93923068T ES 2193144 T3 ES2193144 T3 ES 2193144T3
Authority
ES
Spain
Prior art keywords
epimerase
manuronane
include sequences
sequences coding
dna compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93923068T
Other languages
English (en)
Inventor
Helga Ertesvag
Svein Valla
Gudmund Skjak-Brak
Bjorn Larsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOBIPOL
FMC Biopolymer AS
Original Assignee
NOBIPOL
FMC Biopolymer AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOBIPOL, FMC Biopolymer AS filed Critical NOBIPOL
Application granted granted Critical
Publication of ES2193144T3 publication Critical patent/ES2193144T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/24—Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/831—Azotobacter

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

SE PRESENTAN COMPUESTOS DE DNA QUE COMPRENDEN SECUENCIAS QUE CODIFICAN ENZIMAS QUE TIENEN ACTIVIDAD DE C-5-EPIMERASA DE MANURONAN, ASI COMO UN PROCESO PARA LA PREPARACION DE DICHAS ENZIMAS. LAS SECUENCIAS GENETICAS Y LAS ENZIMAS PREPARADAS PUEDEN USARSE EN LA PRODUCCION DE ALGINATOS QUE TIENEN UNA PROPORCION G/M PRECISA Y UNA ESTRUCTURA DE BLOQUE. LOS ALGINATOS QUE TIENEN UNA PROPORCION G/M PRECISA TAMBIEN PUEDEN PRODUCIRSE MEDIANTE INACTIVACION SELECTIVA DE LAS SECUENCIAS GENETICAS.
ES93923068T 1992-10-08 1993-10-08 Compuestos de dna que comprenden secuencias que codifican manuronano c-5-epimerasa. Expired - Lifetime ES2193144T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221163A GB9221163D0 (en) 1992-10-08 1992-10-08 Dna compounds

Publications (1)

Publication Number Publication Date
ES2193144T3 true ES2193144T3 (es) 2003-11-01

Family

ID=10723148

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93923068T Expired - Lifetime ES2193144T3 (es) 1992-10-08 1993-10-08 Compuestos de dna que comprenden secuencias que codifican manuronano c-5-epimerasa.

Country Status (15)

Country Link
US (1) US5939289A (es)
EP (1) EP0665882B1 (es)
JP (1) JP3665905B2 (es)
KR (1) KR100338997B1 (es)
AT (1) ATE233317T1 (es)
AU (1) AU677796B2 (es)
CA (1) CA2146658C (es)
DE (1) DE69332714T2 (es)
DK (1) DK0665882T3 (es)
ES (1) ES2193144T3 (es)
FI (1) FI120543B (es)
GB (1) GB9221163D0 (es)
NO (1) NO319242B1 (es)
NZ (1) NZ256912A (es)
WO (1) WO1994009124A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701454D0 (sv) 1997-04-18 1997-04-18 Ulf Lindahl new DNA sequences and a process for enzyme manufacture
AU4462600A (en) * 1999-04-12 2000-11-14 Agensys, Inc. Novel prostate-restricted gene expressed in prostate cancer
AU4707700A (en) 1999-05-10 2000-11-21 Hercules Incorporated Sulfohydrolases, corresponding amino acid and nucleotide sequences, sulfohydrolase preparations, processes, and products thereof
KR20080045766A (ko) * 2000-05-26 2008-05-23 아를라 푸즈 에이엠비에이 비피도박테륨에서 단리한 베타-갈락토시다제
CA2436728A1 (en) * 2000-12-08 2002-06-13 Biotie Therapies Corp. Glucuronyl c5-epimerase, dna encoding the same and uses thereof
NO320671B1 (no) * 2001-11-30 2006-01-16 Fmc Biopolymer As Fremgangsmate for a stimulere vektokning i fisk.
NO326145B1 (no) * 2001-11-30 2008-10-06 Fmc Biopolymer As Fremgangsmate for a stimulere vektokning hos pattedyr, fugler og krypdyr.
NO20023581D0 (no) * 2002-07-26 2002-07-26 Fmc Biopolymer As Nye mutantstammer av Pseudomonas fluorescens og varianter derav, metoder for produksjon og bruk derav til produksjon avalginat
FR2849056B1 (fr) * 2002-12-19 2007-07-13 Centre Nat Rech Scient Mannuronane c5-epimerases d'algues brunes, procedes d'obtention et utilisations
DE10349082A1 (de) 2003-10-22 2005-05-25 Wacker-Chemie Gmbh Wässrige Polymerdispersionen
KR101690631B1 (ko) 2007-11-27 2017-01-09 알지파마 아이피알 에이에스 바이오필름 퇴치에 있어서의 알기네이트 올리고머의 용도
WO2009134368A2 (en) * 2008-04-29 2009-11-05 Marshall University Research Corporation Methods of producing bacterial alginates
GB0909529D0 (en) 2009-06-03 2009-07-15 Algipharma Ipr As Alginate oligomers for the inhibition of microbial adherence to surfaces
GB0909557D0 (en) 2009-06-03 2009-07-15 Algipharma Ipr As Anti-microbial alginate oligomers
BRPI1011248A2 (pt) 2009-06-03 2016-03-22 Algipharma As métodos in vitro ou ex vivo de superação de resitência a pelo menos um antibiótico, para combate de contaminação de um sítio e melhora da eficácia de um antibiótico de macrolídeo para inibir o crescimento de bactéria mdr gram negativa, uso de um oligômero de alginato e produto
DE102010062839A1 (de) 2010-12-10 2012-06-14 Wacker Chemie Ag Wässrige, vernetzbare Dispersionen auf der Basis von Organosiliciumverbindungen
GB201116010D0 (en) 2011-09-15 2011-10-26 Algipharma As Use of alginate oligomers to enhance the effects of antifungal agents
GB201305128D0 (en) * 2013-03-20 2013-05-01 Norwegian Univ Sci & Tech Ntnu Epimerases and methods for their identification
GB201322777D0 (en) 2013-12-20 2014-02-05 Algipharma As Use of alginate oligomers as blood anticoagulants
GB201504878D0 (en) 2015-03-23 2015-05-06 Algipharma As Use of alginate oligomers and CFTR modulators in the treatment of conditions associated with CFTR dysfuntion
GB201517639D0 (en) 2015-10-06 2015-11-18 Algipharma As Use of alginate oligomers to treat or prevent microbial overgrowth in the intestinal tract
GB201908639D0 (en) 2019-06-17 2019-07-31 Algipharma Ipr As Use of alginate oligomers in the anticoagulation therapy of subjects at risk of blood clots which have an abnormally dense microstructure
JP2026502943A (ja) 2022-12-30 2026-01-27 アルギファルマ エーエス 経口投与されるポリペプチド治療剤の全身バイオアベイラビリティを高める組成物および方法
WO2026008878A1 (en) 2024-07-04 2026-01-08 Algipharma As Antimycotic polyene-alginate oligomer conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO845059L (no) * 1984-12-17 1986-06-18 Sintef Inst For Marin Biokjemi Fremgangsmaate for fremstilling av alginater med endrede fysikalske egenskaper samt anvendelse av disse alginater.

Also Published As

Publication number Publication date
CA2146658C (en) 2006-03-14
DK0665882T3 (da) 2003-03-31
WO1994009124A1 (en) 1994-04-28
FI951680L (fi) 1995-04-07
ATE233317T1 (de) 2003-03-15
NO951364D0 (no) 1995-04-06
US5939289A (en) 1999-08-17
NO951364L (no) 1995-04-06
FI951680A0 (fi) 1995-04-07
AU677796B2 (en) 1997-05-08
GB9221163D0 (en) 1992-11-25
FI120543B (fi) 2009-11-30
NZ256912A (en) 1997-09-22
DE69332714D1 (de) 2003-04-03
KR950703642A (ko) 1995-09-20
JP3665905B2 (ja) 2005-06-29
AU5287393A (en) 1994-05-09
KR100338997B1 (ko) 2002-11-11
DE69332714T2 (de) 2003-12-11
EP0665882A1 (en) 1995-08-09
EP0665882B1 (en) 2003-02-26
NO319242B1 (no) 2005-07-04
CA2146658A1 (en) 1994-04-28
JPH08504572A (ja) 1996-05-21

Similar Documents

Publication Publication Date Title
ES2193144T3 (es) Compuestos de dna que comprenden secuencias que codifican manuronano c-5-epimerasa.
ES2147720T3 (es) Factor de celulas madre.
ES2134767T3 (es) Recombinacion locoespecifica de dna en celulas vegetales.
ES2065919T3 (es) Ribozimas.
IS4226A (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
ES2018729A6 (es) Un metodo para preparar una variante de activador de plasmogeno de tejido.
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
DE3868076D1 (de) Heterocyclische derivate, verfahren zu ihrer herstellung und diese derivate als aktive bestandteile enthaltende fungizide.
ATE136030T1 (de) Azaheterocyclylmethyl-chromane als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
ES2053719T3 (es) Dimetilvermectinas no naturales y procedimiento para su preparacion.
ATE299854T1 (de) Chinonverbindungen zur behandlung von krankheiten
DE69702705D1 (de) Kondensierte pyrrolo(2,3-c) carbazole-6-one die die aktivität von gamma interferon potenzieren
DE69030765D1 (de) Medien zur zellzucht und verfahren dazu
ES2196140T3 (es) Procedimientos para reducir la concentracion de arn en una mezcla de material biologico utilizando tierra de diatomeas.
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
PT84089B (pt) Sequencias de adn codificando para proteinas possuindo a actividade biologica dos inibidores de husi-tipo i, processos biotecnologicos para a preparacao das referidas proteinas e de composicoes farmaceuticas contendo as referidas proteinas
MX9301235A (es) DERIVADOS 1,4-DIOXINO(2,3-B)PIRIDINA. á
ES2032317T3 (es) Derivados de quinazolina tetraciclicos, obtencion y empleo.
ES2054777T3 (es) Metodo para la preparacion de o-carboxiarilimidazolinonas.
ES2059472T3 (es) Plantas con color de las flores modificado y procedimiento biotecnologico para su obtencion.
DE69331216D1 (de) Planze resistent gegen mindestens zwei viren und dessen preparation
ES8704469A1 (es) Procedimiento para preparar naftoxacinas
BG46743A3 (en) Method for preparing of alkanoyl anilides
ES2068318T3 (es) Herramientas diamantadas ligadas con cobalto, procedimiento para la fabricacion de las mismas asi como su uso.
ATE231486T1 (de) Optisch aktive 2-amino-tetraline, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten und die nützlich sind zur vorbeugung und behandlung von septischem schock